Schedule of Weighted Average Exercise Prices for Options Outstanding
Disclosure of Weighted Average Exercise Prices for Options Outstanding [Table Text Block]
Disclosure of Weighted Average Exercise Prices for Options Outstanding
Cancellation of Debt Income
Cancellation Of Debt Income
Cancellation Of Debt Income
Subsidiary notes payable
Subsidiary Notes Payable [Member]
Subsidiary Notes Payable
Kiran Mazumdar-Shaw
Kiran Mazumdar-Shaw [Member]
Kiran Mazumdar-Shaw
Tax credits
Tax credits expiring
Unused tax credits for which no deferred tax asset recognised
Purchase of property and equipment
Purchase of property, plant and equipment, classified as investing activities
RSU
Restricted Share Units (RSU) [Member]
Restricted Share Units (RSU) [Member]
Uncertain tax positions
Uncertain Tax Positions, Percent
Uncertain Tax Positions, Percent
Loss with respect to associate for which no deferred tax asset is recognized
Rate of loss with respect to associate for which no deferred tax asset is recognized, reconciliation of effective tax rate
Rate of loss with respect to associate for which no deferred tax asset is recognized, reconciliation of effective tax rate
Salaries and wages
Wages and salaries
Subsidiary operating companies
Subsidiary operating companies [Abstract]
Subsidiary operating companies
Proportion of ownership interests held by non-controlling interests
Proportion of ownership interests held by non-controlling interests
Entity File Number
Entity File Number
Income Tax Type [Axis]
Income Tax Type [Axis]
Income Tax Type
Write-off
Write-off amount
Impairment loss recognised in profit or loss, intangible assets other than goodwill
Total deferred income tax expense/(benefit)
Deferred tax expense (income)
Schedule of Cost and Accumulated Amortization of Intangible Assets
Disclosure of detailed information about intangible assets [text block]
All levels of fair value hierarchy
Levels of fair value hierarchy [domain]
0.01
Exercise Price Range One [Member]
Exercise Price Range One [Member]
Two to three years
Later than two years and not later than three years [member]
Nondeductible compensation
Executive compensation, reconciliation of effective tax rate
Executive compensation, reconciliation of effective tax rate
Schedule of Sensitivity Analysis of Fair Value Measurement to Changes in Unobservable Inputs, Liabilities
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, liabilities [text block]
Tax Effected
Tax Effected [Member]
Tax Effected
Other
Other tax effects for reconciliation between accounting profit and tax expense (income)
Sale of shares
Sale of shares
Sales, fair value measurement, assets
Sale of investments held at fair value
Other cash receipts from sales of equity or debt instruments of other entities, classified as investing activities
Net finance income/(costs)
Net finance income/(costs)
Finance income (cost)
Schedule of Quantitative Information About Right-of-use Assets and Lease Liability
Disclosure of quantitative information about right-of-use assets [text block]
Fair Value Measurements
Description of accounting policy for fair value measurement [text block]
Ranges of exercise prices for outstanding share options [axis]
Ranges of exercise prices for outstanding share options [axis]
Purchases of short-term investments
Purchase of financial instruments, classified as investing activities
Within Three Months
Within Three Months [Member]
Within Three Months
Vested (in shares)
Number of other equity instruments exercised or vested in share-based payment arrangement
Investments held at fair value
Carrying amount, beginning balance
Carrying amount, ending balance
Non-current financial assets at fair value through profit or loss
New Standards and Interpretations
Disclosure of changes in accounting policies [text block]
Conversion of Vedanta note to preferred shares
Financial Investments, Gain (Loss) Recognized Through Conversion Of Notes To Preferred Shares
Financial Investments, Gain (Loss) Recognized Through Conversion Of Notes To Preferred Shares
Payables to related parties
Payables to related parties
Consolidated Statement of Comprehensive Income/(Loss)
Statement of comprehensive income [abstract]
Statement of changes in equity [line items]
Statement of changes in equity [line items]
Comprehensive income/(loss) attributable to:
Comprehensive income attributable to [abstract]
Total minimum liquidation preference
Minimum liquidation preference
Minimum liquidation preference
Weighted average grant date fair value, RSU vested (in GBP per share)
Weighted average grant date fair value of other equity instruments Vested in share-based payment arrangement
Weighted average grant date fair value of other equity instruments Vested in share-based payment arrangement
Grant revenue
Income from government grants
Investment in associates – equity method
Carrying amount of Investment in associates
Beginning balance
Ending balance
Investments in associates reported in separate financial statements
Profit/(loss) for the period
Retained earnings, profit (loss) for reporting period
Controlled founded entities
Controlled Founded Entities
Controlled Founded Entities Segment [Member]
Controlled Founded Entities Segment
Time-based RSUs
Time Based RSUs [Member]
Time Based RSUs
General and administrative
General And Administrative [Member]
General And Administrative
Equity - Acquired Share capital PureTech LLC [Line Items]
Equity - Acquired Share capital PureTech LLC [Line Items]
Equity - Acquired Share capital PureTech LLC
Available Funds
Statement of financial position [abstract]
Ensof Holdings, LLC (held indirectly through Enlight)
Ensof Holdings LLC [Member]
Ensof Holdings LLC
Other income/(expense)
Other operating income (expense)
Cover [Abstract]
Other Financial Assets [Abstract]
Other Financial Assets [Abstract]
Investment in associates
Investment In Associates [Member]
Investment In Associates
Provisions
Description of accounting policy for provisions [text block]
Recognition of deferred tax assets and tax benefits not previously recognized
Tax Rate Effect of deferred tax assets and benefits not previously recognised
Tax Rate Effect of deferred tax assets and benefits not previously recognised
Subsidiaries and Change in Subsidiary Ownership and Loss of Control
Description of accounting policy for subsidiaries [text block]
Expiring [Domain]
Expiring [Domain]
Expiring [Domain]
Classes of intangible assets other than goodwill [axis]
Classes of intangible assets other than goodwill [axis]
Tax losses and tax credits carryforwards [Line Items]
Tax losses and tax credits carryforwards [Line Items]
Tax losses and tax credits carryforwards [Line Items]
Number of shares issuable based on performance conditions (in shares)
Number of shares issuable based on performance conditions
Number of shares issuable based on performance conditions
Directors and Senior Managers
Directors and Senior Managers [Member]
Directors and Senior Managers
Entity Shell Company
Entity Shell Company
Loss with respect to associate for which no deferred tax asset is recognized
Loss with respect to associate for which no deferred tax asset is recognized , reconciliation of effective tax rate
Loss with respect to associate for which no deferred tax asset is recognized, reconciliation of effective tax rate
Schedule of Tax Balances as Presented in Consolidated Statement of Financial Position
Disclosure of tax balances as presented in Statement of Financial Position [Table Text Block]
Disclosure of tax balances as presented in Statement of Financial Position
Share premium
Share premium
Cash flows from financing activities:
Cash flows from (used in) financing activities [abstract]
Other
Other, non-controlling interest, equity
Other, non-controlling interest, equity
Basis of Presentation
Description Of Accounting Policy For Basis Of Presentation [Policy Text Block]
Description Of Accounting Policy For Basis Of Presentation
Gelesis
Gelesis [Member]
Gelesis
Deconsolidation of subsidiary
Rate of deconsolidation adjustments, reconciliation of effective tax rate
Rate of deconsolidation adjustments, reconciliation of effective tax rate
Total comprehensive income/(loss) for the year
Total comprehensive income/(loss)
Share of comprehensive income/(loss)
Comprehensive income
Schedule of Credit Risk
Disclosure of credit risk [text block]
Changes in the value of subsidiary preferred shares [Line Items]
Changes in the value of subsidiary preferred shares [Line Items]
Changes in the value of subsidiary preferred shares
Consolidated cash, cash equivalents and short-term investments
Cash And Cash Equivalents, And Short-term Investments
Cash And Cash Equivalents, And Short-term Investments
Document Fiscal Period Focus
Document Fiscal Period Focus
Minimum liquidation preference [Line Items]
Minimum liquidation preference [Line Items]
Minimum liquidation preference
Related parties
Total for all related parties [member]
Non-cash items:
Non-cash items [Abstract]
Non-cash items
Equity Instruments Issued by the Group
Description of accounting policy for equity instruments issued by the group [Policy Text Block]
Description of accounting policy for equity instruments issued by the group
Total assets
Assets
Other
Other inflows (outflows) of cash, classified as investing activities
Purchase of treasury stock (in shares)
Purchase of treasury stock (in shares)
Number Of Treasury Shares Purchased
Number Of Treasury Shares Purchased
Number of simulations
Valuation Technique, Performance Stock Pricing Model, Number Of Simulations
Valuation Technique, Performance Stock Pricing Model, Number Of Simulations
Taxation
Description of accounting policy for income tax [text block]
Equity-accounted associates – share of other comprehensive income/(loss)
Gains (losses) on exchange differences on translation of foreign operations, before tax
Entity's total for associates
Associates [domain]
Outstanding (Non-vested), beginning of year (in shares)
Outstanding (Non-vested), end of year (in shares)
Number of RSUs held (in shares)
Number of other equity instruments outstanding in share-based payment arrangement
Beginning balance
Ending balance
Non-current Liabilities, Royalty Liabilities
Non-current Liabilities, Royalty Liabilities
Investment, Name [Domain]
Investment, Name [Domain]
Trading Symbol
Trading Symbol
Issuance of promissory note
Issuance Of Promissory Note, Fair Value
Issuance Of Promissory Note, Fair Value
Transferred at a point in time
Goods or services transferred at point in time [member]
Total revenue
Revenue
Customer B
Customer B [Member]
Customer B
Entity Address, City or Town
Entity Address, City or Town
Total
Total payroll costs
Payroll Costs
Payroll Costs
Share Capital
Issued capital [member]
Royalty Pharma
Royalty Pharma [Member]
Royalty Pharma
Classes of other provisions [domain]
Classes of other provisions [domain]
Other reserve
Other reserves [member]
Rentable area (in square feet)
Lease Liability, Rentable Area
Lease Liability, Rentable Area
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, assets [line items]
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, liabilities [line items]
Unsecured promissory note
Unsecured Promissory Note Receivable [Member]
Unsecured Promissory Note Receivable
Entity Emerging Growth Company
Entity Emerging Growth Company
Deconsolidation of Subsidiary
Increase (decrease) through change in equity of subsidiaries, equity
Exercise of stock options (in shares)
Increase (decrease) in number of ordinary shares issued
Segment Information [Abstract]
Segment Information [Abstract]
Accounting Policies - Subsidiaries [Table]
Accounting Policies - Subsidiaries [Table]
Accounting Policies - Subsidiaries
US federal statutory rate
Tax expense (income) at applicable tax rate
Disposals
Disposals/Impairment
Disposals, property, plant and equipment
Range of Exercise Prices (in GBP per share)
Exercise price range (in dollars per share)
Exercise price of outstanding share options
Prepaid expenses
Prepaid assets
Current prepaid expenses
Construction in progress
Construction in progress [member]
Three to Twelve Months
Later than three months and not later than one year [member]
Assets
Assets [abstract]
Gain/(loss) – changes in fair value through profit and loss
Gain/(loss) on changes in fair value
Gains (losses) recognised in profit or loss excluding exchange differences, fair value measurement, assets
Right of use assets
Right-of-use assets [member]
Commense Inc.
Commense [Member]
Commense
Recognised Income Tax Expense [Line Items]
Recognised Income Tax Expense [Line Items]
Recognised Income Tax Expense
Repayment of short-term note from associate
Payment of other short term debt
Payment of other short term debt
Proceed from transaction fees
Proceed from Transaction Fees
Proceed from Transaction Fees
Share price at grant date
Weighted average share price, share options granted
Current assets
Current assets [abstract]
Other
Other current payables
Entity Address, Postal Zip Code
Entity Address, Postal Zip Code
Operating Expense Category [Domain]
Operating Expense Category [Domain]
Operating Expense Category [Domain]
Revenue [abstract]
Revenue [abstract]
Repurchase and cancellation of ordinary shares from Tender Offer (in shares)
Repurchase And Cancellation Of Shares
Repurchase And Cancellation Of Shares
Subsidiary operating companies
Subsidiary Operating Companies [Member]
Subsidiary Operating Companies
Non-current assets
Non-current assets [abstract]
Presentation of leases for lessee [abstract]
Finance Income/(Costs), net
Disclosure of finance cost [text block]
Non-audit related services
Auditor's remuneration for other services
Customer A
Customer A [Member]
Customer A
General and administrative expenses
General and administrative expenses
General and administrative
General and administrative expenses
General and administrative expense
Taxation
Disclosure of income tax [text block]
Document and Entity Information [Line Items]
Document Information [Line Items]
Convertible Notes
Subsidiary Convertible Notes [Member]
Subsidiary Convertible Notes
IFRS 15, Revenue from Contracts with Customers
Description of accounting policy for recognition of revenue [text block]
Schedule of Earnings/(Loss) per Share
Schedule of Earnings per Share [Table Text Block]
Schedule of Earnings per Share
Investment in Notes from Associates [Abstract]
Investment in Notes from Associates [Abstract]
Investment in Notes from Associates
Schedule of Lease Liabilities
Disclosure of Lease Liabilities [Table Text Block]
Disclosure of Lease Liabilities
Schedule of Stock Option Activity
Disclosure of number and weighted average exercise prices of share options [text block]
Percentage of royalties received above annual threshold
Royalty Agreement, Percentage Of Royalties Received Above Annual Threshold
Sale Of Future Royalties Liability, Percentage Of Royalties Received Above Annual Threshold
Current year losses and credits for which no deferred tax asset is recognized
Current Year Losses And Credits For Which No Deferred Tax Asset Is Recognized, Amount
Current Year Losses And Credits For Which No Deferred Tax Asset Is Recognized, Amount
Deconsolidation of subsidiary - (Seaport)
Deconsolidation
Deconsolidation
State taxes, net of federal effect
Rate of Effects of state tax rate in US
Rate of Effects of state tax rate in US
Unrecognized deferred tax assets [Table]
Unrecognized deferred tax assets [Table]
Unrecognized deferred tax assets [Table]
Deconsolidated former subsidiary operating companies
Deconsolidated former subsidiaries [Abstract]
Deconsolidated former subsidiaries
Related party transactions [abstract]
Related party transactions [abstract]
Tax credits
Rate Of Tax credits, Reconciliation Of Effective Tax Rate
Rate Of Tax credits, Reconciliation Of Effective Tax Rate
May Warrants
May Warrants [Member]
May Warrants
Cash flows from investing activities:
Cash flows from (used in) investing activities [abstract]
Group's share of net assets (net deficit)
Share of net assets
Share of net assets
Risk-free interest rate
Risk free interest rate, share options granted
Cost associated with Tender Offer not yet paid in cash
Repurchase of ordinary shares not yet paid in cash
Repurchase of ordinary shares not yet paid in cash
Sale of future royalties liability, current
Sale of future royalties liability, current
Current Liabilities, Royalty Liabilities
Current Liabilities, Royalty Liabilities
Inactive subsidiaries
Inactive subsidiaries [Abstract]
Inactive subsidiaries
Investments in Associates
Investment in Notes from Associates
Disclosure of associates [text block]
Equity-settled share-based awards expense
Equity settled share-based payments
Increase (decrease) through share-based payment transactions, equity
Legal proceedings contingent liability
Legal proceedings contingent liability [member]
Total non-current assets
Non-current assets
Non-current assets
Proportion of ownership interest in associate
Group's share in %
Proportion of ownership interest in associate
Number of options held (in shares)
Number of Options held
Number of Options held
Subsidiary Preferred Shares [Abstract]
Subsidiary Preferred Shares [Abstract]
Subsidiary Preferred Shares [Abstract]
Share-based Payments Table [Line Items]
Share-based Payments Table [Line Items]
Share-based Payments Table
Classes of property, plant and equipment [axis]
Classes of property, plant and equipment [axis]
Classes of property, plant and equipment [domain]
Classes of property, plant and equipment [domain]
Other income/(expense)
Other gains (losses)
Entity Address, Country
Entity Address, Country
Subsidiary preferred shares
Subsidiary Preferred Shares [Member]
Subsidiary Preferred Shares
Entity Address, State or Province
Entity Address, State or Province
Number of other equity instruments granted in share-based payment arrangement, fully vested
Number of other equity instruments granted in share-based payment arrangement, fully vested
Number of other equity instruments granted in share-based payment arrangement, fully vested
Schedule of Investments Held at Fair Value
Summary Of Investments Held At Fair Value [Table Text Block]
Summary Of Investments Held At Fair Value
Proceeds from sale of equity investment
Proceeds From Sale Of Equity Investment
Proceeds From Sale Of Equity Investment
Other general and administrative expenses
Other Selling General And Administrative Expense 1
Other Selling General And Administrative Expense 1
Convertible promissory note
Convertible Promissory Note [Member]
Convertible Promissory Note
Weighted average stock price of share options exercised in share-based payment arrangement (in GBP per share)
Weighted average stock price of share options exercised in share-based payment arrangement
Weighted average stock price of share options exercised in share-based payment arrangement
Foreign Currency
Description of accounting policy for foreign currency translation [text block]
Impairment of fixed assets
Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss
Document Annual Report
Document Annual Report
Changes in the value of subsidiary preferred shares [Table]
Changes in the value of subsidiary preferred shares [Table]
Changes in the value of subsidiary preferred shares [Table]
Geographical areas
Geographical areas [domain]
Realized (gain)/loss on sale of investments
Adjustments for losses (gains) on disposal of non-current assets
Revenue
Disclosure of revenue [text block]
Trade and other receivables
Trade and other current receivables
Capital and Financial Risk Management
Disclosure of financial risk management [text block]
Sale of future royalties liability, non-current
Sale of Future Royalties Liability, Non-Current
Sale of Future Royalties Liability, Non-Current
Entity Interactive Data Current
Entity Interactive Data Current
Lighthouse Capital Partners VI, L.P
Lighthouse Capital Partners VI, L.P [Member]
Lighthouse Capital Partners VI, L.P
Interest income from financial assets
Interest Income From Financial Assets
Interest Income From Financial Assets
Acquisition of net asset
Acquisition Of Net Asset
Acquisition Of Net Asset
Receivables due from related parties
Receivables due from related parties
Subsidiary Preferred Shares
Disclosure of Subsidiary Preferred Shares [Text Block]
Disclosure of Subsidiary Preferred Shares
Non-Controlling Interests [Abstract]
Non-Controlling Interests [Abstract]
Non-Controlling Interests [Abstract]
Disclosure of Maturity Analysis of Operating Lease Payments [Table]
Disclosure of maturity analysis of operating lease payments [table]
Basis of Measurement
Description Of Accounting Policy For Basis of Measurement [Policy Text Block]
Description Of Accounting Policy For Basis of Measurement
Receipts from Royalty Purchase Agreement
Proceeds From Sale Of Future Royalties
Proceeds From Sale Of Future Royalties
Series A-2 Preferred Shares
Series A-2 Preferred Shares [Member]
Series A-2 Preferred Shares
Levels of fair value hierarchy [axis]
Levels of fair value hierarchy [axis]
Dr Robert Langer
Dr Robert Langer [Member]
Dr Robert Langer
Total parent equity
Equity attributable to owners of parent [member]
Sale Of Future Royalties Liability [Table]
Sale Of Future Royalties Liability [Table]
Sale Of Future Royalties Liability [Table]
Subsidiary Preferred Shares [Table]
Subsidiary Preferred Shares [Table]
Subsidiary Preferred Shares [Table]
Number of entities established
Number Of Entities Established
Number Of Entities Established
Gain/(loss) on Deconsolidation of Subsidiary
Loss of Control of Subsidiary [Text Block]
Loss of Control of Subsidiary
Finance costs – contractual
Total finance costs – contractual
Finance costs
Jefferies International Limited
Jefferies International Limited [Member]
Jefferies International Limited
Equity - Acquired Share capital PureTech LLC [Table]
Equity - Acquired Share capital PureTech LLC [Table]
Equity - Acquired Share capital PureTech LLC [Table]
Income taxes expense/(benefit)
Adjustments for income tax expense
Leases - Rental [Line Items]
Leases - Rental [Line Items]
Leases - Rental [Line Items]
Material Accounting Policies
Disclosure of material accounting policy information [text block]
Financial Liabilities
Description of accounting policy for financial liabilities [text block]
Revaluation of deferred due to rate change
Tax Rate Effect Of Adjustments Related To Change In Blend State Rate
Tax Rate Effect Of Adjustments Related To Change In Blend State Rate
Royalty income
Royalty income
Entity Central Index Key
Entity Central Index Key
Share-based compensation expense for non-executive directors
Expense from share-based payment transactions with parties other than employees
Merger reserve
Merger reserve [member]
Outstanding at beginning of period (in shares)
Outstanding at end of period (in shares)
Number of share options (in shares)
Number of share options outstanding in share-based payment arrangement
Valuation techniques used in fair value measurement [axis]
Valuation techniques used in fair value measurement [axis]
Financial Instruments [Abstract]
Financial Instruments [Abstract]
Financial Instruments [Abstract]
Operating loss carryforwards not subject to expiration
Operating Loss Carryforwards Not Subject To Expiration [Member]
Operating Loss Carryforwards Not Subject To Expiration
Number of days after debt incurred from a certain investor
Debt Instrument, Payment Term, Number Of Days After Debt Incurred From A Certain Investor
Debt Instrument, Payment Term, Number Of Days After Debt Incurred From A Certain Investor
Income/(loss) attributable to:
Profit (loss), attributable to [abstract]
Equity and liabilities
Equity and liabilities [abstract]
Note receivable
Note Receivable [Member]
Note Receivable
Entity Filer Category
Entity Filer Category
Share-based Payment Expense Category [Axis]
Share-based Payment Expense Category [Axis]
Share-based Payment Expense Category
Series A-1 Preferred Stock
Series A-1 Preferred Stock [Member]
Series A-1 Preferred Stock
Denominator:
Denominator [Abstract]
Denominator
New Standards and Interpretations Not Yet Adopted [Abstract]
New Standards and Interpretations Not Yet Adopted [Abstract]
Additions, net of transfers
Additions other than through business combinations, property, plant and equipment
Deferred revenue
Adjustments for increase decrease In deferred revenue
Adjustments for increase decrease In deferred revenue
Investment in Seaport – deconsolidation
Investments In Associates, Increase Upon Deconsolidation
Investments In Associates, Increase Upon Deconsolidation
Operating income/(loss)
Profit (loss) from operating activities
Sale Of Future Royalties Liability [Line Items]
Sale Of Future Royalties Liability [Line Items]
Sale Of Future Royalties Liability [Line Items]
Number of tranches
Stock Repurchase Program, Number Of Tranches
Stock Repurchase Program, Number Of Tranches
Audit of these financial statements
Auditor's remuneration for audit services
Entity Address, Address Line One
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Two
Leases and subleases
Disclosure of leases [text block]
Over 10 percent of revenue
Over 10 percent of revenue [Member]
Over 10 percent of revenue
Eligibility to receive additional payment amount (up to)
Royalties Liabilities, Eligibility To Receive Additional Royalty Payment, Amount
Royalties Liabilities, Eligibility To Receive Additional Royalty Payment, Amount
Weighted average grant date fair value, RSU outstanding beginning balance (in GBP per share)
Weighted average grant date fair value, RSU Ending balance (in GBP per share)
Weighted average grant date fair value of other equity instruments outstanding in share-based payment arrangement
Weighted average grant date fair value of other equity instruments outstanding in share-based payment arrangement
Lease At 6 Tide Street
Lease At 6 Tide Street [Member]
Lease At 6 Tide Street
Schedule of Weighted-Average Number of Ordinary Shares
Weighted-Average Number of Ordinary Shares [Table Text Block]
Weighted-Average Number of Ordinary Shares
Interest rate
Borrowings, Interest Period, Interest Rate
Borrowings, Interest Period, Interest Rate
Statement of cash flows [abstract]
Disclosure of financial assets [table]
Disclosure of financial assets [table]
Other
Other inflows (outflows) of cash, classified as operating activities
Supplemental disclosure of non-cash investment and financing activities:
Supplemental disclosure of non-cash investment and financing activities [Abstract]
Supplemental disclosure of non-cash investment and financing activities
Weighted average exercise price, options forfeited and expired (in GBP per share)
Weighted Average Exercise Price Of Share Options Forfeited And Expired In Share-based Payment Arrangement
Weighted Average Exercise Price Of Share Options Forfeited And Expired In Share-based Payment Arrangement
Counterparty Name [Domain]
Counterparty Name [Domain]
Operating Loss Carryforwards, Expiration Periods [Domain]
Operating Loss Carryforwards, Expiration Periods [Domain]
Operating Loss Carryforwards, Expiration Periods
Ensof Biosystems, Inc. (held indirectly through Enlight)
Ensof Biosystems Inc [Member]
Ensof Biosystems Inc
Operating expenses:
Operating Expense [Abstract]
Operating Expense
Current liabilities
Current liabilities [abstract]
Schedule of Financial Information of Investments in Associates
Summary of Financial Information For Investments In Associates [Table Text Block]
Summary of Financial Information For Investments In Associates
Amounts received at closing
Royalties Liabilities, Initial Payment Received At Closing
Royalties Liabilities, Initial Payment Received At Closing
Amortization
Amortisation expense
Schedule of Estimated Useful Life of Assets
Disclosure Of Estimated Useful Life Of Assets [Table Text Block]
Disclosure Of Estimated Useful Life Of Assets
Other comprehensive income/(loss):
Other comprehensive income [abstract]
Schedule of Accumulated Depreciation and Impairment Loss
Disclosure of accumulated depreciation and impairment loss [Table Text Block]
Disclosure of accumulated depreciation and impairment loss
1.00 to 2.00
Exercise Price Range Two [Member]
Exercise Price Range Two [Member]
Related party transactions [Table]
Related party transactions [Table]
Related party transactions
Share capital
Classes of share capital [domain]
Share-based payments
Share-based payments [Member]
Share-based payments
Current Liabilities From Share based Payment Transactions
Current Liabilities From Share based Payment Transactions
Current Liabilities From Share based Payment Transactions
Schedule of Terms and Conditions of Share-Based Payment Arrangement
Disclosure of terms and conditions of share-based payment arrangement [text block]
Fair value of warrants
Fair Value Of Warrants
Fair Value Of Warrants
Numerator:
Numerator [Abstract]
Numerator
Share-based Payment Expense [Abstract]
Share-based Payments [Abstract]
Share-based Payments [Abstract]
Classes of contingent liabilities [domain]
Classes of contingent liabilities [domain]
Finance income
Total finance income
Finance income
Classes of financial liabilities [axis]
Classes of financial liabilities [axis]
Financial liabilities, class
Classes of financial liabilities [domain]
Basis of consolidation
Description Of Accounting Policy For Basis Of Consolidation [Policy Text Block]
Description Of Accounting Policy For Basis Of Consolidation
Document Shell Company Report
Document Shell Company Report
Sale of Future Royalties Liability
Description Of Accounting Policy For Sale Of Future Royalties Liability [Policy Text Block]
Description Of Accounting Policy For Sale Of Future Royalties Liability
Purchase of intangible assets not yet paid in cash
Purchase Of Intangible Assets But Not Yet Paid
Purchase Of Intangible Assets But Not Yet Paid
Total
Average number of employees
Appeering Inc.
Appeering
Appeering [Member]
Appeering
Undiscounted operating lease payments to be received
Undiscounted operating lease payments to be received
Lease liability, number of renewal options
Lease Liability, Number Of Renewal Periods
Lease Liability, Number Of Renewal Periods
Balance at beginning of period
Balance at end of period
Total lease liability
Total lease liability
Lease liabilities
Non-trading holding companies
Nontrading Holding Companies [Member]
Nontrading Holding Companies
Auditor Information [Abstract]
Auditor Information
Timing of transfer of goods or services [axis]
Timing of transfer of goods or services [axis]
PureTech LYT, Inc. (formerly Ariya Therapeutics, Inc.)
PureTech LYT [Member]
PureTech LYT
American Depositary Shares
American Depositary Shares [Member]
American Depositary Shares
Deferred Tax Assets and Liabilities [Line Items]
Deferred Tax Assets and Liabilities [Line Items]
Deferred Tax Assets and Liabilities
Deconsolidation During the Year (in shares)
Number Of Share Options Deconsolidated In Share-based Payment Arrangement
Number Of Share Options Deconsolidated In Share-based Payment Arrangement
Profit/(loss) from continuing operations (100%)
Profit (loss) from continuing operations
Inactive subsidiaries
Inactive Subsidiaries [Member]
Inactive Subsidiaries
Schedule of RSU Activity
Disclosure of number and weighted average exercise prices of other equity instruments [text block]
Income/(loss) for the year, attributable to the owners of the Group, dilutive
Profit (loss), attributable to ordinary equity holders of parent entity, used in calculating diluted earnings per share
Enlight Biosciences, LLC
Enlight [Member]
Enlight
Seaport Therapeutics, Inc.
Seaport Therapeutics, Inc. [Member]
Seaport Therapeutics, Inc.
Types of customers
Types of customers [domain]
Share capital
Share capital, £0.01 par value, issued and paid 257,927,489, as of December 31, 2025 and 2024
Issued capital
Intangible assets, net
Intangible assets, net
Intangible assets, net
Lease liability, lease term
Lease Liability, Lease Term
Lease Liability, Lease Term
Tax losses
Tax losses expiring
Unused tax losses for which no deferred tax asset recognised
Convertible Notes [Line Items]
Convertible Notes [Line Items]
Convertible Notes
Exercise of stock options
Increase (decrease) through exercise of options, equity
Gain/(loss) on investments held at fair value
Gains (losses) recognised in profit or loss including exchange differences, fair value measurement, assets
Preferred A-1, A-2 And B
Preferred A-1, A-2 And B [Member]
Preferred A-1, A-2 And B
Timing of transfer of goods or services
Timing of transfer of goods or services [domain]
Exercise price (GBP) (in GBP per share)
Exercise price, share options granted
Issued ordinary shares (in shares)
Number of shares outstanding
Subsidiary Notes Payable - Loans [Line Items]
Subsidiary Notes Payable - Loans [Line Items]
Subsidiary Notes Payable - Loans
Other provisions
Other provisions
Trade and other payables
Adjustments for increase (decrease) in trade accounts payable
Other temporary differences
Other temporary differences [member]
Total
Financial liabilities
Deconsolidated former subsidiary operating companies
Deconsolidated former Subsidiary Operating Companies [Member]
Deconsolidated former Subsidiary Operating Companies
Revenue [Line Items]
Revenue [Line Items]
Revenue
Tax benefit/(expense)
Income tax expense/(benefit)
Income tax expense/(benefit)
Income tax expense/(benefit)
Tax expense (income)
Disclosure of information of employees [Line Items]
Disclosure of information of employees [Line Items]
Disclosure of information of employees [Line Items]
Libra Biosciences, Inc.
Libra Biosciences Inc [Member]
Libra Biosciences Inc
Subsequent Events
Disclosure of events after reporting period [text block]
Disclosure of maturity analysis of operating lease payments [line items]
Disclosure of maturity analysis of operating lease payments [line items]
Uncertain tax positions
Uncertain Tax Positions, Amount
Uncertain Tax Positions, Amount
Nonexecutive Directors
Nonexecutive Directors [Member]
Nonexecutive Directors
Proceeds from maturity of short-term investments
Proceeds from sales or maturity of financial instruments, classified as investing activities
Document Transition Report
Document Transition Report
Trade and other receivables
Trade and other receivables
Cash flows from operating activities:
Cash flows from (used in) operating activities [abstract]
Cash derecognized upon loss of control over subsidiary
Cash In Deconsolidated Subsidiary
Cash In Deconsolidated Subsidiary
Share of net income/(loss) of associates accounted for using the equity method
Share of net (gain)/loss of associates accounted for using the equity method
Share of profit (loss) of associates and joint ventures accounted for using equity method
PureTech Securities Corp.
PureTech Securities Corp. [Member]
PureTech Securities Corp.
Finance costs – non-cash interest expense related to sale of future royalties
Total finance costs - non-cash interest expense related to sale of future royalties
Non-cash interest expense recognized
Noncash Interest Expense, Royalty Liability
Noncash Interest Expense, Royalty Liability
Expense (income) in respect of RSU liability award
Expense (income) in respect of RSU liability award
Expense (income) in respect of RSU liability award
Document Period End Date
Document Period End Date
Lease Contractual Term [Domain]
Lease Contractual Terms [Domain]
Lease Contractual Term [Domain]
Non-adjusting events after reporting period
Non-adjusting events after reporting period [domain]
Disclosure of range of exercise prices of outstanding share options [line items]
Disclosure of range of exercise prices of outstanding share options [line items]
Maturity [axis]
Maturity [axis]
Other
Other inflows (outflows) of cash, classified as financing activities
Classes of financial instruments [axis]
Classes of financial instruments [axis]
Unrecognized goodwill and intangibles
Goodwill
Michele Holcomb
Michele Holcomb [Member]
Michele Holcomb
Associates [axis]
Associates [axis]
Share-based Payments Table [Table]
Share-based Payments Table [Table]
Share-based Payments Table [Table]
Document Type
Document Type
Share-based payments
Share-based payment expense
Expense from share-based payment transactions with employees
Share options expiration period from grant date
Share-Based Payment Arrangement, Expiration Period
Share-Based Payment Arrangement, Expiration Period
Classes of financial assets [axis]
Classes of financial assets [axis]
Notes payable
Notes and debentures issued
Unrecognized deferred tax assets [Line Items]
Unrecognized deferred tax assets [Line Items]
Unrecognized deferred tax assets [Line Items]
Profit or loss [abstract]
Disclosure of financial liabilities [abstract]
Stock-based compensation
Rate of Share based Payment expenses, non-deductible, reconciliation of effective tax rate
Rate of Share based Payment expenses, non-deductible
Deferred tax assets (liabilities), net, not recognized
Total
Net deferred tax assets, not recognised
Net deferred tax assets, not recognised
Operating segments
Operating segments [member]
Four to five years
Later than four years and not later than five years [member]
Share-based payment arrangements
Types of share-based payment arrangements [domain]
Payroll taxes
Payroll Taxes
Payroll Taxes
Wholly-Owned Programs
Wholly-owned Segment [Member]
Wholly-owned Segment
Subsidiary Notes Payable [Abstract]
Subsidiary Notes Payable [Abstract]
Subsidiary Notes Payable [Abstract]
Conversion of note receivable from associate into preferred shares
Conversion Of Note Receivable From Associate Into Preferred Shares
Conversion Of Note Receivable From Associate Into Preferred Shares
Performance-based RSUs
Performance Based RSUs [Member]
Performance Based RSUs
Equity attributable to the owners of the Group
Equity attributable to owners of parent
Earnings/(loss) per share:
Earnings per share [abstract]
Range [axis]
Range [axis]
Components of equity [axis]
Components of equity [axis]
Deconsolidation of subsidiary (Seaport)
Increase (decrease) through disposal of subsidiary, equity
Sale of Future Royalties Liability
Disclosure of financial liabilities [text block]
Sharon Barber-Lui
Sharon Barber-Lui [Member]
Sharon Barber-Lui
Total RSUs
Restricted share units [member]
Calculated gain on deconsolidation
Gain on Deconsolidation
Gain on Deconsolidation
Disclosure of financial liabilities [line items]
Disclosure of financial liabilities [line items]
Income/(loss) before taxes
Income/(loss) before taxes
Profit (loss) before tax
Weighted average remaining contractual life of options excisable
Weighted average remaining contractual life of options excisable
Weighted average remaining contractual life of options excisable
Liquidity Risk [Line Items]
Liquidity Risk [Line Items]
Liquidity Risk
Gain/(loss) on foreign currency exchange
Gain Loss on foreign currency exchange in finance costs
Gain Loss on foreign currency exchange in finance costs
Vor Biopharma Inc.
Vor
Vor [Member]
Vor
Schedule of Liquidity Risk
Disclosure of liquidity risk [text block]
Entity's total for related parties
Categories of related parties [domain]
Preferred stock, series B
Preferred stock, series B [Member]
Preferred stock, series B
Convertible preferred stock, conversion shares (in shares)
Convertible Preferred Stock, Conversion Shares
Convertible Preferred Stock, Conversion Shares
Sonde, After Financing
Sonde, After Financing [Member]
Sonde, After Financing
Financial instruments, class
Classes of financial instruments [domain]
Gelesis, Inc.
Gelesis, Inc. [Member]
Gelesis, Inc.
Gross Amount
Gross Amount [Member]
Gross Amount
Auditor Location
Auditor Location
Non-Controlling Interests [Table]
Non-Controlling Interests [Table]
Non-Controlling Interests
Interest received
Interest received, classified as operating activities
Karuna, Vor and Akili
Karuna, Vor and Akili [Member]
Karuna, Vor and Akili
Schedule of Operating Segments
Disclosure of operating segments [text block]
Weighted average number of ordinary shareholders to calculate basic earnings per share (in shares)
Weighted average number of ordinary shares used in calculating basic earnings per share
Recognised Income Tax Expense [Table]
Recognised Income Tax Expense [Table]
Recognised Income Tax Expense [Table]
Contractual interest expense on notes payable
Contractual Interest expense on notes
Contractual Interest expense on notes
Schedule of Unrecognized Deferred Tax Assets
Disclosure of temporary difference, unused tax losses and unused tax credits [text block]
Award settlement, price per share
Share-Based Compensation Arrangement By Share-Based Payment Award, Award Settlement, Price Per Share
Share-Based Compensation Arrangement By Share-Based Payment Award, Award Settlement, Price Per Share
Disclosure of detailed information about intangible assets [table]
Disclosure of detailed information about intangible assets [table]
Other reserve
Other reserves
Other reserves
Share-based payment expense
Key management personnel compensation, share-based payment
Convertible notes
Convertible Notes [Member]
Convertible Notes
Changes in the fair value of the notes
Gains (losses) on financial assets at fair value through profit or loss
Entity Well-known Seasoned Issuer
Entity Well-known Seasoned Issuer
Weighted Average Options outstanding [Table]
Weighted Average Options outstanding [Table]
Weighted Average Options outstanding [Table]
Senior secured convertible promissory note
Senior Secured Convertible Promissory Note [Member]
Senior Secured Convertible Promissory Note
Options exercisable (in shares)
Number of share options exercisable in share-based payment arrangement
Computer equipment and software
Computer equipment [member]
Investments held at fair value [Table]
Investments held at fair value [Table]
Investments held at fair value
Customers over 10% of revenue
Major customers [domain]
Net cash provided by (used in) financing activities
Cash flows from (used in) financing activities
Subsidiary Plans [Table]
Subsidiary Plans [Table]
Subsidiary Plans [Table]
Preferred
Preference shares [member]
Vedanta and Gelesis
Vedanta and Gelesis [Member]
Vedanta and Gelesis
Gallop
Gallop Oncology [Member]
Gallop Oncology
Schedule of Recognized Income Tax Expense
Disclosure of recognized income tax expense [Table Text Block]
Disclosure of recognized income tax expense
Accumulated depreciation and impairment loss
Accumulated depreciation, amortisation and impairment [member]
Financial Assets
Description of accounting policy for financial assets [text block]
Entity Current Reporting Status
Entity Current Reporting Status
Treasury stock
Treasury shares, 16,243,451 and 18,506,177 as of December 31, 2025 and 2024, respectively
Treasury shares
Schedule of Deferred Taxes
Disclosure of deferred taxes [text block]
2.00 to 3.00
Exercise Price Range Three [Member]
Exercise Price Range Three [Member]
Investment in Vedanta preferred shares
Investment in Vedanta preferred shares
Increase through origination or purchase, financial assets
Accounting Policies
Accounting Policies [Line Items]
Accounting Policies
Expiring term after issuance
Warrants, Expiration Term
Warrants, Expiration Term
Statement of changes in equity [table]
Statement of changes in equity [table]
Non-Controlling Interests [Line Items]
Non-Controlling Interests [Line Items]
Non-Controlling Interests
Minimum liquidation preference [Table]
Minimum liquidation preference [Table]
Minimum liquidation preference [Table]
Gain/(loss) from changes in fair value of warrant liability
Gain/(Loss) from change in fair value of warrant liability
Gain/(Loss) from change in fair value of warrant liability
Merger reserve
Merger reserve
Merger reserve
PureTech Management, Inc.
PureTech Management [Member]
PureTech Management
Current Fiscal Year End Date
Current Fiscal Year End Date
Proceeds from sale of property and equipment
Proceeds from sales of property, plant and equipment, classified as investing activities
Taxation [Table]
Taxation [Table]
Taxation
Cash equivalents
Cash equivalents
Total
Credit risk
Credit risk
Market Backsolve & OPM
Market Backsolve & OPM [Member]
Market Backsolve & OPM
Bottom of range
Bottom of range [member]
Categories of related parties [axis]
Categories of related parties [axis]
Impairment of Non-Financial Assets
Description of accounting policy for impairment of non-financial assets [text block]
Schedule of Reconciliation of Effective Tax Rate
Disclosure of Reconciliation of Effective Tax Rate [Table Text Block]
Disclosure of Reconciliation of Effective Tax Rate
Income/(loss) for the year
Net income/(loss)
Income/(loss) for the year
Profit (loss)
Weighted average grant date fair value, RSU forfeited (in GBP per share)
Weighted average grant date fair value of other equity instruments forfeited in share-based payment arrangement
Weighted average grant date fair value of other equity instruments forfeited in share-based payment arrangement
Tax liability – current
Income Tax Payable
Income Tax Payable
Mandara Sciences, LLC
Mandara Sciences LLC [Member]
Mandara Sciences LLC
Schedule of Operating Expenses
Disclosure Of Total Operating Expense Explanatory [Table Text Block]
Disclosure Of Total Operating Expense Explanatory
Schedule of Payroll Costs
Disclosure of Payroll Costs [Table Text Block]
Disclosure of Payroll Costs
Weighted average exercise price (in dollars per share)
Weighted average exercise price, options granted (in GBP per share)
Weighted average exercise price of share options granted in share-based payment arrangement
Total non-current liabilities
Non-current liabilities
Non-current liabilities
Share-based payment arrangements, percentage of common shares outstanding
Share-based Payment Arrangements, Authorized Amount, Percentage of Common Shares Outstanding
Share-based Payment Arrangements, Authorized Amount, Percentage of Common Shares Outstanding
Schedule of Sale of Future Royalties Liability
Schedule Of Royalty Liabilities [Table Text Block]
Schedule Of Royalty Liabilities
Sale of Future Royalties Liabilities [Roll Forward]
Sale of Future Royalties Liabilities [Roll Forward]
Sale of Future Royalties Liabilities
Establishment of new entities
Establishment Of New Entities [Member]
Establishment Of New Entities
Gain on forgiveness of debt
Gain on forgiveness of debt
Gain on forgiveness of debt
Document Registration Statement
Document Registration Statement
Gain/(loss) from changes in fair value of preferred shares
Gain/(Loss) from change in fair value of preferred shares
Gain/(Loss) from change in fair value of preferred shares
Beginning balance number of shares outstanding (in shares)
Ending balance number of shares outstanding (in shares)
Number of shares issued (in shares)
Number of shares issued (in shares)
Number of shares issued
Remuneration expense
Directors' remuneration expense
Segment Information
Disclosure of entity's operating segments [text block]
Operating Expense Category [Axis]
Operating Expense Category [Axis]
Operating Expense Category
Depreciation
Depreciation
Depreciation, right-of-use assets
Temporary difference, unused tax losses and unused tax credits [domain]
Temporary difference, unused tax losses and unused tax credits [domain]
Increase in value of preferred shares measured at fair value – finance income
Change in fair value
Change in fair value
Associates
Total for all associates [member]
Retained earnings/ (accumulated deficit)
Retained earnings [member]
Schedule of Finance Income (Cost)
Disclosure of finance income (cost) [text block]
One to two years
Later than one year and not later than two years [member]
Warrants fair value
Warrants, Fair Value
Warrants, Fair Value
Leases
Description of accounting policy for leases [text block]
Gain on dilution of interest in associates
Gain on Dilution of Interest in Associate
Gain on Dilution of Interest in Associate
Deductible temporary difference
Deductible temporary differences for which no deferred tax asset is recognised
Financial Instruments - Fair value Measurement and Classification [Line Items]
Financial Instruments - Fair value Measurement and Classification [Line Items]
Financial Instruments - Fair value Measurement and Classification
Total amortization and depreciation expenses
Depreciation and amortisation expense
Business Contact
Business Contact [Member]
Liabilities
Liabilities [abstract]
Convertible Notes [Table]
Convertible Notes [Table]
Convertible Notes [Table]
Investment in notes from associates, current
Current receivables due from associates
Lease liability, subleased area (in square feet)
Lease Liability, Subleased Area
Lease Liability, Subleased Area
Trade and other payables due to PureTech
Third Party Payable from IC Upon Deconsolidation
Third Party Payable from IC Upon Deconsolidation
Finance costs
Finance costs [Abstract]
Finance costs
Other Assets And Liabilities, Net
Other Assets And Liabilities, Net
Other Assets And Liabilities, Net
Leases - Rental [Table]
Leases - Rental [Table]
Leases - Rental [Table]
Carrying Amount
Carrying amount [member]
Percentage of reasonably possible increase in unobservable input, assets
Percentage of reasonably possible increase in unobservable input, assets
Subsidiary Types [Domain]
Subsidiary Types [Domain]
Subsidiary Types [Domain]
Unobservable inputs
Unobservable inputs [domain]
Short-term employee benefits
Key management personnel compensation, short-term employee benefits
Security Exchange Name
Security Exchange Name
Number of reportable segments
Number Of Reportable Segment
Number Of Reportable Segment
Forfeited During the Year (in shares)
Number of share options forfeited in share-based payment arrangement
Right of use asset, net
Right of use asset, net
Balance at beginning of period
Balance at end of period
Right-of-use assets
Investments held at fair value [Line Items]
Investments held at fair value [Line Items]
Investments held at fair value
Contact Personnel Name
Contact Personnel Name
Probability of entering into an initial public offering ("IPO")
Early and Late IPO Scenario Probability [Member]
Early and Late IPO Scenario Probability
Investments held at fair value
Investments held at fair value [Member]
Investments held at fair value
Purchase of Treasury stock
Purchase of treasury shares
Percentage of voting equity interests acquired
Percentage of voting equity interests acquired
Number of assets written off in the period
Number Of Assets Written Off
Number Of Assets Written Off
Opening net assets/(liabilities)
Opening Net Assets/(Liabilities)
Opening Net Assets/(Liabilities)
Revaluation of deferred due to rate change
Adjustments Related To Change In Blend State Rate
Adjustment Related To Change In Blend State Rate
Settlement of restricted stock units (in shares)
Number Of Ordinary Shares Issued To Settle Share-based Payment Awards
Number Of Ordinary Shares Issued To Settle Share-based Payment Awards
Percent voting rights of the company
Percent voting rights of the Company
Percent voting rights of the Company
Current receivable due from associates, interest rate
Current Receivable Due From Associates, Interest Rate
Current Receivable Due From Associates, Interest Rate
Schedule of Income Taxes Recognized in Comprehensive Income
Disclosure of Income Taxes Recognized in Comprehensive Income [Table Text Block]
Disclosure of Income Taxes Recognized in Comprehensive Income
Subsidiary Preferred Shares [Line Items]
Subsidiary Preferred Shares [Line Items]
Subsidiary Preferred Shares
Schedule of Equity
Summary of Equity [Table Text Block]
Summary of Equity
Debt instruments held measured at fair value through other comprehensive income
Debt instruments held measured at fair value through other comprehensive income
State taxes, net of federal effect
Effects of state tax rate in US, reconciliation of effective tax rate
Effects of state tax rate in US, reconciliation of effective tax rate
Intangible assets other than goodwill
Intangible assets other than goodwill [member]
Payment (from) to Royalty Pharma
Payments (from) to Royalty Pharma
Payment To (From) Royalty Pharma
Payment To (From) Royalty Pharma
Taxation [Line Items]
Taxation [Line Items]
Taxation
Receivables due from associates
Receivables due from associates
Financial assets
Balance at beginning of period
Balance at end of period
Financial assets, at fair value
Potential securities excluded from diluted EPS calculation (in shares)
Number of potential ordinary shares that are antidilutive in period presented
Closing net assets/(liabilities)
Closing Net Assets / (Liabilities)
Closing Net Assets / (Liabilities)
Performance, market and service based RSU
Performance, market and service based RSU [Member]
Performance, market and service based RSU
Operating tax losses
Unused tax losses [member]
Income Tax Type [Domain]
Income Tax Type [Domain]
Income Tax Type [Domain]
Translation reserve
Reserve of exchange differences on translation [member]
Net assets/(liabilities)
Net assets attributable to shareholders of associate
Net assets attributable to shareholders of associate
Tax liability
Tax liability [Member]
Tax liability
Directors and Senior Managers Shareholdings and Share Incentive awards [Table]
Directors and Senior Managers Shareholdings and Share Incentive awards [Table]
Directors and Senior Managers Shareholdings and Share Incentive awards
PureTech Securities II Corp.
PureTech Securities II Corp. [Member]
PureTech Securities II Corp.
Equity Value
Equity Value, Measurement Input [Member]
Equity Value, Measurement Input
Total operating expenses
Total operating expenses
Operating expense
Classes of share capital [axis]
Classes of share capital [axis]
Rental income
Rental income
Number of share options exercised (in dollars per share)
Exercised (in shares)
Exercised During the Year (in shares)
Number of share options exercised in share-based payment arrangement
Equity method income (loss)
Share of profit (loss) of associates accounted for using equity method
2023 Performance Share Plan
2023 Performance Share Plan [Member]
2023 Performance Share Plan
Total equity
Equity at beginning of period
Equity at end of period
Equity
Entity Addresses, Address Type [Axis]
Entity Addresses, Address Type [Axis]
Property and equipment, net
Balance at beginning of period
Balance at end of period
Property, plant and equipment
Settlement of restricted stock units through issuance of equity
Ordinary Shares Issued To Settle Share-based Payment Awards
Ordinary Shares Issued To Settle Share-based Payment Awards
Series A-1 preferred
Series A-1 Preferred [Member]
Series A-1 Preferred
Number of shares held (in shares)
Number Of Shares Held
Number Of Shares Held
Vedanta
Vedanta [Member]
Vedanta
Disclosure of associates [Line Items]
Disclosure of associates [Line Items]
Disclosure of associates
Development Costs
Description of accounting policy for research and development expense [text block]
Level 1
Level 1 of fair value hierarchy [member]
Number of shares acquired per share (in euro per share)
Number Of Shares, Acquired, Per Share
Number Of Shares, Acquired, Per Share
Number of share options granted in share-based payment arrangement (in shares)
Granted (in shares)
Granted During the Year (in shares)
Number of share options granted in share-based payment arrangement
Use of Judgments and Estimates
Description Of Accounting Policy For Use Of Judgement And Estimates [Policy Text Block]
Description Of Accounting Policy For Use Of Judgement And Estimates
Property, plant and equipment
Disclosure of detailed information about property, plant and equipment [line items]
Stock options
Stock Options [Member]
Stock Options
Percentage of reasonably possible decrease in unobservable input, assets
Percentage of reasonably possible decrease in unobservable input, assets
Effect of shares issued & treasury shares purchased (in shares)
Dilutive Effect Of All Instruments On Weighted Average Number Of Ordinary Shares, Including Effect Of Treasury Shares Purchased And Cancelled
Dilutive Effect Of All Instruments On Weighted Average Number Of Ordinary Shares, Including Effect Of Treasury Shares Purchased And Cancelled
Commitments And Contingencies [Abstract]
Commitments And Contingencies [Abstract]
Interest rate, repayment period
Borrowings, Repayment Period, Interest Rate
Borrowings, Repayment Period, Interest Rate
Level 2
Level 2 of fair value hierarchy [member]
Disclosure of non-adjusting events after reporting period [abstract]
Liability for share-based awards
Noncurrent Liabilities From Share based Payment Transactions
Noncurrent Liabilities From Share based Payment Transactions
SPTX, Inc. (held Indirectly through Seaport)
SPTX, Inc. (held Indirectly through Seaport) [Member]
SPTX, Inc. (held Indirectly through Seaport)
Furniture and fixtures
Fixtures and fittings [member]
Weighted-average exercise price, beginning of year (in GBP per share)
Weighted-average exercise price, end of year (in GBP per share)
Wtd Average Exercise Price (in GBP per share)
Weighted-average exercise price (in dollars per share)
Weighted average exercise price of share options outstanding in share-based payment arrangement
Owners of the Group
Profit (loss), attributable to owners of parent
2015 Performance Share Plan
2015 Performance Share Plan [Member]
2015 Performance Share Plan
Finance income/(costs) – fair value accounting
Rate of finance income costs - fair value accounting, reconciliation of effective tax rate
Rate of finance income costs - fair value accounting, reconciliation of effective tax rate
Audit of the financial statements of associate
Audit of financial statements of associates
Audit of financial statements of associates
Karuna Therapeutics, Inc.
Karuna
Karuna [Member]
Karuna
Customers over 10% of revenue
Major customers [axis]
Seaport
Seaport [Member]
Seaport
Short-term investments
Short-term investments
Short-term Investment
Short-term Investment
Principal amount
Financial Asset, Principal Amount
Financial Asset, Principal Amount
Deferred revenue
Deferred tax assets (liabilities), net
Deferred tax liability (asset)
Lease liability, renewal term
Lease Liability, Renewal Term
Lease Liability, Renewal Term
Total current liabilities
Current liabilities
Current liabilities
Number of shares acquired (in shares)
Investments Held At Fair Value, Number Of Shares Acquired
Investments Held At Fair Value, Number Of Shares Acquired
Gain/(loss) on deconsolidation of subsidiary
Gain on deconsolidation of subsidiary
Gains (losses) recognised when control of subsidiary is lost
Deferred tax assets
Deferred tax assets
Non-controlling interests
Non-controlling interests [member]
Non-controlling interests
Comprehensive income, attributable to non-controlling interests
Document Accounting Standard
Document Accounting Standard
Net assets from bankruptcy
Net Assets From Bankruptcy [Member]
Net Assets From Bankruptcy
Sale of future royalties
Future Royalties [Member]
Future Royalties
Weighted average remaining contractual life of outstanding share options
Weighted average remaining contractual life of outstanding share options
Sublease, write off
Lease Receivable, Sublease, Write Off
Lease Receivable, Sublease, Write Off
Share-based liability awards
Share based liabilty awards [Member]
Share based liabilty awards
Tax credits
Tax Credit, Reconciliation Of Effective Tax Rate
Tax Credit, Reconciliation Of Effective Tax Rate
State - current
State [Member]
State
Share-based Payments
Description of accounting policy for share-based payment transactions [text block]
Short-term note to associate
Cash Receipts From Repayment Of Current Receivables Due From Associates, Classified As Investing Activities
Cash Receipts From Repayment Of Current Receivables Due From Associates, Classified As Investing Activities
Statement of changes in equity [abstract]
Retained earnings/(Accumulated deficit)
Retained earnings/(accumulated deficit)
Retained earnings
Aggregated measurement
Measurement [domain]
Input Value
Significant unobservable input, assets
Research and development
Research And Development [Member]
Research And Development
Number of associate's common stock held at fair value (in shares)
Number of associate common stock held at fair value
Number of associate common stock held at fair value
Number of other equity instruments granted in share-based payment arrangement
RSUs Granted in Period (in shares)
Number of other equity instruments granted in share-based payment arrangement
Gain on deconsolidation of subsidiary
Adjustments for gain (loss) on disposal of investments in subsidiaries, joint ventures and associates
Finance income/(costs):
Finance income/(costs) [Abstract]
Finance income/(costs)
Sale of equity instruments in other entities (in shares)
Sale of equity instruments in other entities
Sale of equity instruments in other entities
Trade and other receivables
Adjustments for decrease (increase) in trade and other receivables
Commitments and Contingencies [Table]
Commitments and Contingencies [Table]
Commitments and Contingencies
Legal Entity [Axis]
Legal Entity [Axis]
Vedanta Biosciences, Inc.
Vedanta Biosciences
Vedanta Biosciences [Member]
Vedanta Biosciences
Subsidiaries [axis]
Subsidiaries [axis]
Income/(loss) for the year, attributable to the owners of the Group, basic
Profit (loss), attributable to ordinary equity holders of parent entity, used in calculating basic earnings per share
Schedule of Earnings/(Loss) Attributable to Owners of Company
Earnings Loss attributable to owners of company [Table Text Block]
Earnings Loss attributable to owners of company
Interest paid
Interest paid, classified as operating activities
Performance based RSU
Performance based RSU [Member]
Performance based RSU
Disclosure of financial liabilities [table]
Disclosure of financial liabilities [table]
Laboratory and manufacturing equipment
Laboratory and Manufacturing Equipment [Member]
Laboratory and Manufacturing Equipment
Operating Segments
Description of accounting policy for segment reporting [text block]
Cancellation of Debt Income
Cancellation of Debt Income Percentages
Cancellation of Debt Income Percentages
Investment in convertible notes from associates
Purchase Of Convertible Notes And Warrants From Associates, Classified As Investing Activities
Purchase Of Convertible Notes And Warrants From Associates, Classified As Investing Activities
Geographical areas [axis]
Geographical areas [axis]
Investment in preferred shares held at fair value
Purchase of interests in associates
Other financial assets
Restricted cash
Restricted cash and cash equivalents
Number of shares issued and fully paid (in shares)
Number of shares issued and fully paid
Expiration of share options in subsidiary
Decrease In Non-controlling From Expiration Of Share Options In Subsidiary
Decrease In Non-controlling From Expiration Of Share Options In Subsidiary
Lease liability, non-current
Long-term portion of lease liability
Non-current lease liabilities
Capital And Financial Risk Management [Abstract]
Capital And Financial Risk Management
Schedule of Revenue
Disclosure of revenue from contracts with customers [text block]
Within 10 years
Not later than 10 years [Member]
Not later than 10 years
Entity Common stock
Entity Common Stock, Shares Outstanding
Balance at beginning of period
Balance at end of period
Intangible assets
Intangible assets other than goodwill
Document Financial Statement Error Correction
Document Financial Statement Error Correction [Flag]
Akili Interactive Labs, Inc.
Akili Interactive Labs [Member]
Akili Interactive Labs
Segments
Segments [domain]
Schedule of Subsidiary Preferred Shares, Minimum Liquidation Preference
Summary of Minimum liquidation preference [Table Text Block]
Summary of Minimum liquidation preference
Cash and cash equivalents
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year
Cash and cash equivalents
Cash and cash equivalents
Schedule of Investments in Associates
Summary Of Investments In Associates [Table Text Block]
Summary Of Investments In Associates
Total Income Tax Type
Total Income Tax Type [Member]
Total Income Tax Type
PureTech LYT 100, Inc.
PureTech LYT - 100 [Member]
PureTech LYT - 100
Document and Entity Information [Table]
Document Information [Table]
Fixed price
Number Of Shares, Acquired, Fixed Price
Number Of Shares, Acquired, Fixed Price
Translation reserve
Reserve of exchange differences on translation
Related Parties Transactions
Disclosure of transactions between related parties [text block]
Total equity and liabilities
Equity and liabilities
US
UNITED STATES
Property, plant and equipment [abstract]
Share-based Payment [Line Items]
Share-based Payment [Line Items]
Share-based Payment
Number of Shares/Units
Share-Based Arrangement [Roll Forward]
Share-Based Arrangement
Beginning balance
Ending balance
Non-current Financial Assets At Fair Value Through Profit Or Loss, Before Allocation Of Equity Method Loss
Non-current Financial Assets At Fair Value Through Profit Or Loss, Before Allocation Of Equity Method Loss
Gains (losses) on change in fair value of equity investments
Gains (Losses) On Change In Fair Value Of Equity Investments
Gains (Losses) On Change In Fair Value Of Equity Investments
Disclosure of information of employees [Table]
Disclosure of information of employees [Table]
Disclosure of information of employees [Table]
Commitments and Contingencies [Line Items]
Commitments and Contingencies [Line Items]
Commitments and Contingencies [Line Items]
Number of shares acquired
Number Of Shares, Acquired
Number Of Shares, Acquired
Schedule of Range of Exercise Prices of Outstanding Share Options
Disclosure of range of exercise prices of outstanding share options [text block]
All Subsidiaries
All Subsidiaries [Member]
All Subsidiaries
Depreciation
Depreciation expense
Value of shares authorized to be repurchased
Stock Repurchase Program, Shares Authorized to be Repurchased
Stock Repurchase Program, Shares Authorized to be Repurchased
Finance (income)/costs, net
Adjustments For Finance Costs (Income)
Adjustments For Finance Costs (Income)
Expired During the Year (in shares)
Number of share options expired in share-based payment arrangement
City Area Code
City Area Code
Royalty rate
Royalty Income, Rate
Royalty Income, Rate
Convertible Notes [Roll Forward]
Convertible Notes [Roll Forward]
Convertible Notes
Useful life measured as period of time, property, plant and equipment
Useful life measured as period of time, property, plant and equipment
Gain/(loss) on investments in notes from associates
Loss on investments in notes from associates
Gain (Loss) On Investment In Notes Receivable From Associates
Gain (Loss) On Investment In Notes Receivable From Associates
Liability for share-based awards, short-term
Other payables, liability settled share based awards
Other payables, liability settled share based awards
Money Markets
Loans to corporate entities [member]
Other
Increase (decrease) through other changes, equity
More than five years
Later than five years [member]
Expiring [Axis]
Expiring [Axis]
Expiring
Financial assets, class
Classes of financial assets [domain]
Intangible Assets
Disclosure of intangible assets [text block]
Level 3 of fair value hierarchy
Level 3
Level 3 of fair value hierarchy [member]
Interest expense on lease liability
Interest expense
Interest expense on lease liabilities
Trade and other payables
Trade and other payables
Unobservable inputs [axis]
Unobservable inputs [axis]
Auditor Name
Auditor Name
Schedule of Property and Equipment, Net
Schedule of Property & Equipment net [Table Text Block]
Schedule of Property & Equipment net
Entity's total for segment consolidation items
Segment consolidation items [domain]
Disclosure of disaggregation of revenue from contracts with customers [line items]
Disclosure of disaggregation of revenue from contracts with customers [line items]
PureTech Health LLC
PureTech Health LLC
PureTech Health [Member]
PureTech Health
Schedule of Changes in the Value of Subsidiary Preferred Shares
Changes in the value of subsidiary preferred shares [Table Text Block]
Changes in the value of subsidiary preferred shares
Number of votes per ordinary share
Number Of Votes Per Ordinary Share
Number Of Votes Per Ordinary Share
Business Or Sourcing Company [Domain]
Business Or Sourcing Company [Domain]
Business Or Sourcing Company [Domain]
Liquidity Risk [Table]
Liquidity Risk [Table]
Liquidity Risk [Table]
Expected term (in years)
Option life, share options granted
Capital And Financial Risk Management [Table]
Capital And Financial Risk Management [Table]
Capital And Financial Risk Management
Net cash provided by (used in) operating activities
Cash flows from (used in) operating activities
Forfeited (in shares)
Number of other equity instruments forfeited in share-based payment arrangement
Disclosure of terms and conditions of share-based payment arrangement [line items]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Non-current liabilities
Non-current liabilities [abstract]
Loss of equity method investment
Gain (Loss) of Equity Method Investment
Gain (Loss) of Equity Method Investment
Entity [Domain]
Entity [Domain]
Share-based Payments
Disclosure of share-based payment arrangements [text block]
Weighted Average Options Outstanding [Line Items]
Weighted Average Options Outstanding [Line Items]
Weighted Average Options Outstanding
Disclosure of detailed information about intangible assets [abstract]
Document Fiscal Year Focus
Document Fiscal Year Focus
Liability for share-based awards
Liabilities from share-based payment transactions
Adjustments to reconcile income/(loss) for the period to net cash used in operating activities:
Adjustments to reconcile profit (loss) [abstract]
Capitalized research & development expenditures
Capitalized Research And Experimental Expenditures [Member]
Capitalized Research And Experimental Expenditures
Deconsolidation of subsidiary
Increase (Decrease) From Adjustment To Loss Of Control Of Subsidiary, Intangible Assets Other Than Goodwill
Increase (Decrease) From Adjustment To Loss Of Control Of Subsidiary, Intangible Assets Other Than Goodwill
Forfeited and expired (in shares)
Number Of Share Options Forfeited And Expired In Share-Based Payment Arrangement
Number Of Share Options Forfeited And Expired In Share-Based Payment Arrangement
Trade and other payables
Trade and other payables [Member]
Trade and other payables
Stock sold, price per share (usd per share)
Investment, Sold, Price Per Share
Investment, Sold, Price Per Share
Subsidiary notes payable
Beginning balance
Ending balance
Current financial liabilities
Current financial liabilities
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, assets [table]
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, liabilities [table]
Seaport, Vedanta And Sonde
Seaport, Vedanta And Sonde [Member]
Seaport, Vedanta And Sonde
Schedule of Share-Based Payment Expense as Reflected in the Consolidated Statement of Income/(Loss)
Share-based Payment Expense Table [Text Block]
Share-based Payment Expense Table
Stock-based compensation
Share based Payment expenses, non-deductible, reconciliation of effective tax rate
Share based Payment expenses, non-deductible, reconciliation of effective tax rate
Investment in Sonde convertible note
Increase (decrease) in financial assets
Classes of other provisions [axis]
Classes of other provisions [axis]
Operating Loss Carryforwards, Expiration Periods [Axis]
Operating Loss Carryforwards, Expiration Periods [Axis]
Operating Loss Carryforwards, Expiration Periods
Going Concern
Description Of Accounting Policy For Going Concern [Policy Text Block]
Description Of Accounting Policy For Going Concern
Milestone payment recieved
Milestone Payment Received
Milestone Payment Received
Leasehold improvements
Leasehold improvements [member]
New Standards and Interpretations
Disclosure of expected impact of initial application of new standards or interpretations [text block]
Accounting Policies - Property and Equipment [Table]
Accounting Policies - Property and Equipment [Table]
Accounting Policies - Property and Equipment [Table]
Revenue [Table]
Revenue [Table]
Revenue
Worthless stock deduction
Tax Rate Effect Of Stock Deduction, Reconciliation Of Effective Tax Rate
Tax Rate Effect Of Stock Deduction, Reconciliation Of Effective Tax Rate
Seaport Therapeutics (Common)
Seaport Therapeutics [Member]
Seaport Therapeutics
Aggregated number of shares repurchased under share repurchase program (in shares)
Stock Repurchase Program, Aggregated Number Of Shares Repurchased
Stock Repurchase Program, Aggregated Number Of Shares Repurchased
Entrega, Inc. (indirectly held through Enlight)
Entrega
Entrega [Member]
Entrega
Schedule of Changes in Assets, Level 3 Fair Value, Investments Held at Fair Value
Disclosure of changes in assets, level 3 fair value - investments held at fair value [Table Text Block]
Disclosure of changes in assets, level 3 fair value - investments held at fair value
Schedule of Subsidiary Share-Based Payments
Disclosure of Subsidiary Share-based Payment Plans [Table Text Block]
Disclosure of Subsidiary Share-based Payment Plans
Trade payables
Current trade payables
Key management personnel compensation
Total
Key management personnel compensation
Expiry for equity settlement period
Employee Stock Ownership Plan (ESOP), Expiration Period
Employee Stock Ownership Plan (ESOP), Expiration Period
Vedanta Biosciences Securities Corp. (indirectly held through Vedanta)
Vedanta Biosciences Securities Corp [Member]
Vedanta Biosciences Securities Corp
Realized gain/(loss) on sale of investments
Losses on disposals of investments
Common
Ordinary shares [member]
Trade and other receivables
Current trade receivables
Effect of dilutive shares (in shares)
Dilutive effect of share options on weighted average number of ordinary shares
Changes in operating assets and liabilities:
Changes in operating assets and liabilities [Abstract]
Changes in operating assets and liabilities
Schedule of Auditors' Remuneration
Disclosure of auditors' remuneration [text block]
Earnings/(Loss) per Share
Disclosure of earnings per share [text block]
Cost
Gross carrying amount [member]
Gross carrying amount [member]
Trade and other payables
Total trade and other payables
Trade and other current payables
US federal statutory rate
Applicable tax rate
Accrued expenses
Accruals classified as current
Number of shares issued by investee (in shares)
Number of shares issued by investee held by PureTech
Number of shares issued by investee held by PureTech
Repurchase and cancellation of ordinary shares from Tender Offer
Repurchase And Cancellation Of Shares, Amount
Repurchase And Cancellation Of Shares, Amount
Local Phone Number
Local Phone Number
Forgiveness of debt – entity dissolution – finance income
Payoff of Principal & Interest
Payoff of Principal & Interest
Proceeds from the issuance of shares and subsidiary preferred shares
Proceeds from issuing shares
Less than one year
Not later than one year [member]
Schedule of Key Management Personnel Compensation
Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [text block]
Total
Auditor's remuneration
Annual threshold, amount
Royalty Agreement, Annual Threshold Royalty Payment Made To Counterparty
Royalty Agreement, Annual Threshold Royalty Payment Made To Counterparty
Property and equipment, net
Property, plant and equipment [member]
Disclosure of financial assets [line items]
Disclosure of financial assets [line items]
Property and Equipment
Description of accounting policy for property, plant and equipment [text block]
Investment, Name [Axis]
Investment, Name [Axis]
Investments Held at Fair Value
Disclosure of Investments Held at Fair Value [Text Block]
Disclosure of Investments Held at Fair Value
Payment of lease liability
Cash paid for rent - principal - financing cash flow
Payments of lease liabilities, classified as financing activities
Entity Voluntary Filers
Entity Voluntary Filers
Unrecognized equity method losses
Adjustments for undistributed profits of investments accounted for using equity method
Preferred share liability
Beginning balance
Ending balance
Preferred Share Liability
Preferred Share Liability
Available Indefinitely
Available indefinitely [Member]
Available indefinitely
Entity Registrant Name
Entity Registrant Name
Basic earnings/(loss) per share (in dollars per share)
Basic earnings/(loss) per share (in dollars per share)
Basic earnings (loss) per share
Equity method loss recorded against LTI, net
Gain (Loss) On Equity Method Investment
Gain (Loss) On Equity Method Investment
Measurement [axis]
Measurement [axis]
Disclosure of interests in Subsidiaries [Table]
Disclosure of interests in Subsidiaries [Table]
Disclosure of interests in Subsidiaries [Table]
Directors and Senior Managers Shareholdings and Share Incentive awards [Line Items]
Directors and Senior Managers Shareholdings and Share Incentive awards [Line Items]
Directors and Senior Managers Shareholdings and Share Incentive awards
Weighted average number of ordinary shareholders to calculate diluted earnings per share (in shares)
Weighted average number of ordinary shares used in calculating diluted earnings per share
Repurchase of ordinary shares from Tender Offer, including associated costs
Payment for repurchase of ordinary shares, tender offer
Payment for repurchase of ordinary shares, tender offer
Alivio Therapeutics, Inc.
Alivio [Member]
Alivio
Proceeds from group
Proceeds From Group
Proceeds From Group
Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets
Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets
Classes of intangible assets other than goodwill [domain]
Classes of intangible assets other than goodwill [domain]
Disclosure of associates [table]
Disclosure of associates [table]
Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, assets
Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, assets
Share-based compensation expense
Adjustments for share-based payments
Finance income/(costs) – fair value accounting
Finance income costs - fair value accounting, reconciliation of effective tax rate
Finance income costs - fair value accounting, reconciliation of effective tax rate
Senior Managers
Senior Managers [Member]
Senior Managers
Payments in respect of developmental milestones
Estimated financial effect of contingent liabilities
Schedule of Convertible Notes Outstanding
Schedule of Convertible Notes [Table Text Block]
Schedule of Convertible Notes
Associates
Description of accounting policy for investment in associates [text block]
Knode Inc. (indirectly held through Enlight)
Knode
Knode [Member]
Knode
Akili
Akili [Member]
Akili
Non-controlling interests
Derecognize carrying value of non-controlling interest
Non-controlling interests
Exercise price of warrants (in usd per share)
Exercise Price of Warrants
Exercise Price of Warrants
Segment consolidation items [axis]
Segment consolidation items [axis]
Balance at beginning of period before Equity method loss recorded against LTI
Balance at end of period before Equity method loss recorded against LTI
Financial assets, at fair value, before equity method investment
Financial assets, at fair value, before equity method investment loss
Weighted average exercise price of, options exercisable (in GBP per share)
Weighted average exercise price of share options exercisable in share-based payment arrangement
Non-controlling interests
Profit (loss), attributable to non-controlling interests
Equity
Equity [abstract]
3.00 to 4.00
Exercise Price Range Four [Member]
Exercise Price Range Four [Member]
Disclosure of disaggregation of revenue from contracts with customers [table]
Disclosure of disaggregation of revenue from contracts with customers [table]
Exercise of stock options
Proceeds from exercise of options
Prepaid expenses and other financial assets
Adjustments for decrease (increase) in other current assets
Ranges of exercise prices for outstanding share options
Ranges of exercise prices for outstanding share options [domain]
Loans
Loan [Member]
Loan
Deconsolidation gain
Deconsolidation Gain
Deconsolidation Gain
Accrued interest on convertible notes - finance costs
Accrued interest, Convertible Notes
Accrued interest, Convertible Notes
Convertible note, percentage of equity price trigger
Debt Instrument, Convertible, Percentage Of Equity Price Trigger
Debt Instrument, Convertible, Percentage Of Equity Price Trigger
Ownership interest
Ownership Interest
Ownership Interest
ICFR Auditor Attestation Flag
ICFR Auditor Attestation Flag
Payments of withholding taxes in connection with stock-based awards
Payments Of Withholding Taxes In Connection With Share-Based Payment Arrangements
Payments Of Withholding Taxes In Connection With Share-Based Payment Arrangements
Weighted Average Grant Date Fair Value (GBP) (*)
Weighted Average Grant Date Fair Value [Roll Forward]
Weighted Average Grant Date Fair Value
Cash paid for rent - interest - operating cash flow
Cash outflow for leases
Number of business days following the consummation of a qualified financing
Current Receivables Due From Associates, Term, Number Of Business Days Following The Consummation Of A Qualified Financing
Current Receivables Due From Associates, Term, Number Of Business Days Following The Consummation Of A Qualified Financing
Operating Expenses
Disclosure Of Operating Expense [Text Block]
Disclosure Of Operating Expense
Auditor Firm ID
Auditor Firm ID
Post-employment benefits
Key management personnel compensation, post-employment benefits
Related party transactions [Line Items]
Related party transactions [Line Items]
Related party transactions
Proceeds from issue of convertible notes
Proceeds from issue of convertible notes
Proceeds from issue of convertible notes
Share premium
Share premium [member]
(Gain)/loss on investments in notes from associates
Adjustments For Gains (Losses) On Change In Fair Value Of Note Receivable Due From Associates
Adjustments For Gains (Losses) On Change In Fair Value Of Note Receivable Due From Associates
Deferred Tax Assets and Liabilities [Table]
Deferred Tax Assets and Liabilities [Table]
Deferred Tax Assets and Liabilities [Table]
Schedule of Disaggregation of Revenue from Contracts with Customers
Disclosure of disaggregation of revenue from contracts with customers [text block]
Owners of the Group
Comprehensive income, attributable to owners of parent
Worthless stock deduction
Stock Deduction, Reconciliation Of Effective Tax Rate
Stock Deduction, Reconciliation Of Effective Tax Rate
Other research and development expenses
Other Research And Development Expenses
Other Research And Development Expenses
Investment in preferred shares
Financial Investments, Gain (Loss) Recognised Through Profit (Loss) When Control Of Subsidiary Is Lost
Financial Investments, Gain (Loss) Recognised Through Profit (Loss) When Control Of Subsidiary Is Lost
Total liabilities
Liabilities
Other
Other tax rate effects for reconciliation between accounting profit and tax expense (income)
Grant Revenue
Description of accounting policy for government grants [text block]
Dr John LaMattina
Dr John LaMattina [Member]
Dr John LaMattina
Schedule of Unrecognized Tax Losses and Tax Credits Carryforwards
Disclosure of unrecognized tax losses and tax credits, deferred tax assets [Table Text Block]
Disclosure of unrecognized tax losses and tax credits, deferred tax assets
Gain realized on sale of Karuna shares
Gains on disposals of investments
Gains on disposals of investments
Eric Elenko
Dr Eric Elenko [Member]
Dr Eric Elenko
Proceeds from investors
Proceeds From Investors
Proceeds From Investors
Disclosure of subsidiaries [table]
Disclosure of subsidiaries [table]
Uncertain Tax Position
Uncertain Tax Position [Member]
Uncertain Tax Position
Tax liability, current
Current tax liabilities, current
Issuance of subsidiary preferred shares
Proceeds from issue of preference shares
Intangible Assets
Description of accounting policy for intangible assets other than goodwill [text block]
No Trading Symbol Flag
No Trading Symbol Flag
Schedule of Fair Value Measurement and Classification
Disclosure of fair value measurement [text block]
Other Financial Assets
Disclosure of other assets [text block]
Federal - current
Federal [Member]
Federal
Lease liability
Lease liabilities [member]
Proportion of ownership interest in investee (as a percent)
Proportion of ownership interest in investee
Proportion of ownership interest in investee
Interest
Interest On Undiscounted Lease payments
Interest On Undiscounted Lease payments
NCI purchase price of restricted stock award
Increase (Decrease) Through NCI exercise of share-based awards in Subsidiaries
Increase (Decrease) Through NCI exercise of share-based awards in Subsidiaries
Follica, Incorporated
Follica
Follica [Member]
Follica
Property and equipment, net
Property, plant and equipment including right-of-use assets
Financial liabilities, at fair value
Financial liabilities
Financial liabilities, at fair value
Investment in notes from associates, non-current
Non-current receivables due from associates
Total current income tax expense/(benefit)
Current tax expense (income)
Non-adjusting events after reporting period [axis]
Non-adjusting events after reporting period [axis]
One to Five Years
Later than one year and not later than five years [member]
Valuation techniques
Valuation techniques used in fair value measurement [domain]
Top of range
Top of range [member]
Purchase of treasury stock
Payment To Purchase Treasury Stock
Payment To Purchase Treasury Stock
Parent Company and Other
Parent Company And Other [Member]
Parent Company And Other
Share-based awards expiration period
Share-based Compensation Arrangement By Share-based Payment Award, Expiration Period
Share-based Compensation Arrangement By Share-based Payment Award, Expiration Period
Cash consideration
Consideration Paid For Issuance Of Notes Receivable
Consideration Paid For Issuance Of Notes Receivable
Research and development expenses
Research and development expenses
Research and development expenses
Research and development
Research and development expense
Other non-current assets
Other non-current assets
Lease Contractual Term [Axis]
Lease Contractual Terms [Axis]
Lease Contractual Terms
Taxation [Abstract]
Taxation [Abstract]
Taxation [Abstract]
Three to four years
Later than three years and not later than four years [member]
Unrecognized deferred tax asset
Tax effect of tax losses
Additional number of shares authorized to purchase (in shares)
Additional number of shares authorized to purchase
Additional number of shares authorized to purchase
Long-term loan (including current portion)
Non-current portion of non-current loans received
Tax credits
Unused tax credits [member]
Audit-related assurance services
Audit related assurance services
Audit related assurance services
Total other operating expenses
Miscellaneous other operating expense
Recognition of deferred tax assets and tax benefits not previously recognized
Deferred tax assets and benefits not previously recognised, reconciliation of effective tax rate
Deferred tax assets and benefits not previously recognised, reconciliation of effective tax rate
Percentage vote and value of subsidiaries in the Group consolidated state tax return
Percentage vote and value of subsidiaries in the Group consolidated state tax return
Percentage vote and value of subsidiaries in the Group consolidated state tax return
Settlement of restricted stock units
Increase decrease through settlement of restricted stock units
Increase decrease through settlement of restricted stock units
Unrecognized deferred tax asset
Tax rate effect of tax losses
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]
Schedule of Fair Value Measurement Methods
Disclosure Of Fair Value Measurement Methods [Table Text Block]
Disclosure Of Fair Value Measurement Methods
Business Or Sourcing Company [Axis]
Business Or Sourcing Company [Axis]
Business Or Sourcing Company
Borrowings by name
Borrowings by name [domain]
Contract revenue
Revenue from contracts with customers
Functional and Presentation Currency
Description of accounting policy for functional currency [text block]
Number of common shares redeemable from each RSU (in shares)
Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Common Shares Redeemed Per Restricted Share Unit
Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Common Shares Redeemed Per Restricted Share Unit
Deferred tax liabilities
Deferred tax liabilities
Balance at beginning of period after Equity method loss recorded against LTI
Balance at end of period after Equity method loss recorded against LTI
Financial Assets, At Fair Value, After Equity Method Investment loss
Financial Assets, At Fair Value, After Equity Method Investment loss
Share in gain/(loss) of associates
Share of associate loss recorded against long-term interest
Share of associate loss recorded against long-term interest
Share of associate loss recorded against long-term interest
Income taxes paid
Income taxes paid (refund), classified as operating activities
Total other comprehensive income/(loss)
Other comprehensive income/(loss) for the year
Other comprehensive income
Treasury Shares
Treasury shares [member]
Lease liability, initial term
Lease Liability, Initial Term
Lease Liability, Initial Term
Sub-total (net assets)/liabilities
Identifiable assets acquired (liabilities assumed)
Proportion of voting rights held in associate
Proportion of voting rights held in associate
Net increase (decrease) in cash and cash equivalents
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
Types of share-based payment arrangements [axis]
Types of share-based payment arrangements [axis]
Investments held at fair value [Abstract]
Investments held at fair value [Abstract]
Depreciation and amortization
Adjustments for depreciation and amortisation expense
Interest expense on other borrowings
Interest expense on borrowings
Tal Medical, Inc.
Tal [Member]
Tal
Group's share of equity method losses
Gain (Loss) Of Equity Method Investment, Group Share
Gain (Loss) Of Equity Method Investment, Group Share
Title of 12(b) Security
Title of 12(b) Security
Disclosure of subsidiaries [line items]
Disclosure of subsidiaries [line items]
Issuance of Seaport preferred shares – financing cash flow
Issuance of Seaport preferred shares – financing cash flow
Issue of equity
Share held at fair value
Investment, Preferred Share held at Fair Value
Investment, Preferred Share held at Fair Value
Total Subsidiary Types
Total Subsidiary Types [Member]
Total Subsidiary Types
Sublease annual fees
Lessee, Operating Sublease, Annual Lease Fees
Lessee, Operating Sublease, Annual Lease Fees
Disaggregation of Revenue - Customers over 10% of revenue [Table]
Disaggregation of Revenue - Customers over 10% of revenue [Table]
Disaggregation of Revenue - Customers over 10% of revenue
Series Preferred A-2 and B
Series Preferred A-2 and B [Member]
Series Preferred A-2 and B
Award vesting period
Share-Based Payment Arrangements, Award Vesting Period
Share-Based Payment Arrangements, Award Vesting Period
Treasury Shares
Description of accounting policy for treasury shares [text block]
Group's share in gain (net losses)
Share of profit (loss) from continuing operations of associates and joint ventures accounted for using equity method
Sonde Health, Inc.
Sonde
Sonde [Member]
Sonde
Voting percentage through the holdings
Proportion of voting rights held in subsidiary
Endra Holdings, LLC (held indirectly through Enlight)
Endra Holdings LLC [Member]
Endra Holdings LLC
Performance share plan
Performance Share Plan [Member]
Performance Share Plan
Non-trading holding companies
Nontrading holding companies [Abstract]
Nontrading holding companies
Entity's total for subsidiaries
Subsidiaries [domain]
Convertible note receivable
Convertible Note Receivable [Member]
Convertible Note Receivable
Borrowings by name [axis]
Borrowings by name [axis]
Investment in notes from associates, current
Current financial assets
Issued share capital acquired (in shares)
Issued Share capital acquired
Issued Share capital acquired
Trade and Other Payables
Disclosure of trade and other payables [text block]
Schedule of Trade and Other Payables
Schedule of Trade And Other Payables [Table Text Block]
Schedule of Trade And Other Payables
Sublease receivable
Finance lease receivables
Commitments and Contingencies
Disclosure of commitments and contingent liabilities [text block]
Financial Instruments
Disclosure of financial instruments [text block]
Schedule of Cost
Disclosure of detailed information about property, plant and equipment [text block]
Licenses
Licences [member]
Expected dividend yield
Expected dividend, share options granted
Borrowings, interest rate
Borrowings, interest rate
Net cash provided by (used in) investing activities
Cash flows from (used in) investing activities
Disclosure of range of exercise prices of outstanding share options [table]
Disclosure of range of exercise prices of outstanding share options [table]
Investment in notes from associates
Short-term note from associate [Member]
Short-term note from associate
Intangible Assets
Disclosure of detailed information about intangible assets [line items]
Nondeductible compensation
Rate of executive compensation, reconciliation of effective tax rate
Rate of executive compensation, reconciliation of effective tax rate
Investment in notes from associates, non-current
Non-current financial assets
Healthcare and other benefits
Employee benefits expense
Investments in associates accounted for using equity method
Investments in associates accounted for using equity method
Subsidiary [Abstract]
Subsidiary [Abstract]
Subsidiary [Abstract]
Liabilities from share based payment transactions, performance and market conditions met
Liabilities From Share based Payment Transactions, performance and market conditions met
Liabilities From Share based Payment Transactions, performance and market conditions met
Financial Instruments
Description of accounting policy for financial instruments [text block]
Total current assets
Current assets
Current assets
Subsidiary Plans [Line Items]
Subsidiary Plans [Line Items]
Subsidiary Plans
Realized gain/(loss) on sale of investments
Gains (losses) on disposals of investments
Subsidiary Notes Payable
Disclosure of Subsidiary Notes Payable [Text Block]
Disclosure of Subsidiary Notes Payable
Investment in Associates [Abstract]
Investment in Associates [Abstract]
Investment in Associates [Abstract]
Non-cancellable contractual commitments
Contractual capital commitments
Series A convertible preferred stock
Series A Convertible Preferred Stock [Member]
Series A Convertible Preferred Stock
Capital And Financial Risk Management [Line Items]
Capital And Financial Risk Management [Line Items]
Capital And Financial Risk Management
Subsidiary preferred shares and warrants
Subsidiary Preferred Shares
Subsidiary Preferred Shares
Disclosure of operating segments [table]
Disclosure of operating segments [table]
Total income tax expense/(benefit), recognized
Deferred tax expense (income) recognised in profit or loss
Transferred over time
Goods or services transferred over time [member]
Finance income/(costs) – fair value accounting
Total finance income/(costs) – fair value accounting
Gains (losses) recognised in profit or loss including exchange differences, fair value measurement, liabilities
Segments [axis]
Segments [axis]
Recognize investment retained in deconsolidated subsidiary at fair value
Issued capital, preference shares
Subsidiary Types [Axis]
Subsidiary Types [Axis]
Subsidiary Types
Weighted average grant date fair value, RSU granted (in GBP per share)
Weighted average grant date fair value of other equity instruments granted in share-based payment arrangement
Weighted average grant date fair value of other equity instruments granted in share-based payment arrangement
Trade and other payables [abstract]
Schedule of Information about Employees
Schedule Of Information About Employees [Table Text Block]
Schedule Of Information About Employees
(Gain)/loss on investment held at fair value
Adjustments for fair value losses (gains)
Repurchase price per share
Stock Repurchase Program, Price Per Share
Stock Repurchase Program, Price Per Share
Depreciation
Depreciation, property, plant and equipment
Purchase of investments other than investments accounted for using equity method
Purchase of investments other than investments accounted for using equity method
Accounts receivables related to contract revenue
Receivables from contracts with customers
Weighted average exercise price, options exercised (in GBP per share)
Weighted average exercise price of share options exercised in share-based payment arrangement
Income tax receivable
Current tax assets, current
Tax losses and tax credits carryforwards [Table]
Tax losses and tax credits carryforwards [Table]
Tax losses and tax credits carryforwards [Table]
Expected volatility
Expected volatility, share options granted
Par value per share (in GBP per share)
Par value per share
Financial investments, fair value of earnout shares received from SPAC exchange
Financial Investments, Fair Value Of Earnout Shares Received From SPAC Exchange
Financial Investments, Fair Value Of Earnout Shares Received From SPAC Exchange
Property and Equipment
Disclosure of property, plant and equipment [text block]
Schedule of Maturity Analysis of Operating Lease Payments
Disclosure of maturity analysis of operating lease payments [text block]
Gain/(loss) on dilution of ownership interest in associates
Gain on dilution of ownership interest in associates
Gain (Loss) Recognized On Dilution Of Ownership Interest In Associate
Gain (Loss) Recognized On Dilution Of Ownership Interest In Associate
Massachusetts
MASSACHUSETTS
Amendment Flag
Amendment Flag
Equity
Components of equity [domain]
Changes in the value of subsidiary preferred shares [Roll Forward]
Changes in the value of subsidiary preferred shares [Roll Forward]
Changes in the value of subsidiary preferred shares
Subsidiary Notes Payable - Loans [Table]
Subsidiary Notes Payable - Loans [Table]
Subsidiary Notes Payable - Loans [Table]
Disclosure of operating segments [line items]
Disclosure of operating segments [line items]
Non-Controlling Interest
Disclosure of non-controlling interests [text block]
Income tax receivable – current
Trade receivables, income tax receivable
Trade receivables, income tax receivable
Employee Benefits
Description of accounting policy for employee benefits [text block]
Deconsolidation of subsidiaries
Decrease through loss of control of subsidiary, property, plant and equipment
Equity awards issued to third parties
Non controlling interests and options issued to third parties
Non controlling interests and options issued to third parties
Temporary difference, unused tax losses and unused tax credits [axis]
Temporary difference, unused tax losses and unused tax credits [axis]
Payment for settlement
Provision used, other provisions
Termination benefits
Key management personnel compensation, termination benefits
Ranges
Range [domain]
Accounting policies, changes in accounting estimates and errors [Abstract]
Accounting Policies 1 [Abstract]
Accounting Policies 1
Classes of contingent liabilities [axis]
Classes of contingent liabilities [axis]
(Gain)/loss on disposal of assets
Adjustments for gain (loss) on disposals, property, plant and equipment
Deconsolidation of subsidiary
Deconsolidation adjustments, reconciliation of effective tax rate
Deconsolidation adjustments, reconciliation of effective tax rate
Distribution of Assets, Liabilities and Stockholders' Equity
Distribution of Assets, Liabilities and Stockholders' Equity [Table Text Block]
Lease liability, subleased area (in square feet)
Lessee, Operating Sublease, Subleased Area
Lessee, Operating Sublease, Subleased Area
Total share-based payments expense category
Total Share-based Payments Expense Category [Member]
Total Share-based Payments Expense Category
Equity
Disclosure of Equity [Text Block]
Disclosure of Equity
Gallop Oncology, Inc. (Indirectly Held through PureTech LYT)
Gallop Oncology, Inc. (Indirectly Held through PureTech LYT) [Member]
Gallop Oncology, Inc. (Indirectly Held through PureTech LYT)
More than 10 years
Later than ten years [member]
Types of customers [axis]
Types of customers [axis]
Schedule of Directors’ and Senior Managers’ Shareholdings and Share Incentive Awards
Disclosure Of Information About Shareholdings of Key Management Personnel Explanatory [Table Text Block]
Disclosure Of Information About Shareholdings of Key Management Personnel Explanatory
Address Type [Domain]
Address Type [Domain]
Allonia LLC
Allonia LLC [Member]
Allonia LLC
Other
Other Net Assets/Liabilities
Other Net Assets/Liabilities
Interest income on sublease receivable
Interest Income On Sublease Receivable
Interest Income On Sublease Receivable
Lease liability, current
Lease liabilities (including current portion)
Short-term portion of lease liability
Current lease liabilities
Percentage vote and value of subsidiaries included in the Group consolidated federal tax return
Percentage vote and value of subsidiaries included in the Group consolidated federal tax return
Percentage vote and value of subsidiaries included in the Group consolidated federal tax return
Finance income
Finance income [Abstract]
Finance income
Number of warrants (in shares)
Warrants, Number of Securities Called by Warrants
Warrants, Number of Securities Called by Warrants
Series A-2 preferred stock
Series A-2 Preferred Stock [Member]
Series A-2 Preferred Stock
Diluted earnings/(loss) per share (in dollars per share)
Diluted earnings/(loss) per share (in dollars per share)
Diluted earnings (loss) per share
Aggregated time bands
Maturity [domain]
Stock incentive plan
Stock Incentive Plan [Member]
Stock Incentive Plan
Share Capital
Description of accounting policy for issued capital [text block]
Schedule of Changes in Equity Classified Non-controlling Ownership Interests in Subsidiaries
Disclosure of interests in subsidiaries [text block]
Schedule of Subsidiaries
Disclosure of subsidiaries [text block]
Current year losses and credits for which no deferred tax asset is recognized
Current Year Losses And Credits For Which No Deferred Tax Asset Is Recognized, Percent
Current Year Losses And Credits For Which No Deferred Tax Asset Is Recognized, Percent
Other income/(expense):
Other income/(expense) [Abstract]
Other income/(expense)
Disclosure of terms and conditions of share-based payment arrangement [table]
Disclosure of terms and conditions of share-based payment arrangement [table]
Financial Instruments - Fair value Measurement and Classification [Table]
Financial Instruments - Fair value Measurement and Classification [Table]
Financial Instruments - Fair value Measurement and Classification [Table]
Average effective tax rate
Average effective tax rate
At fair value
At fair value [member]
Schedule of Short-term and Long-term Portion of Lease Liability
Disclosure of short-term and long-term portion of lease liability [Table Text Block]
Disclosure of short-term and long-term portion of lease liability
Finance Cost Net [Abstract]
Finance Cost Net [Abstract]
Counterparty Name [Axis]
Counterparty Name [Axis]
Disclosure of associates [line items]
Disclosure of associates [line items]
Property, plant and equipment [Table]
Disclosure of detailed information about property, plant and equipment [table]
Purchases of intangible assets
Purchase of intangible assets, classified as investing activities
Equity method loss recorded against LTI
Equity method loss recorded against LTI
Equity method loss recorded against LTI
Equity Method Loss Recorded Against LTI
Equity Method Loss Recorded Against LTI
Entity Incorporation, State or Country Code
Entity Incorporation, State or Country Code
Finance Income and Finance Costs
Description of accounting policy for finance income and costs [text block]